TY  - JOUR
AU  - Pun, Matthew
AU  - Pratt, Drew
AU  - Nano, Patricia R
AU  - Joshi, Piyush K
AU  - Jiang, Li
AU  - Englinger, Bernhard
AU  - Rao, Arvind
AU  - Cieslik, Marcin
AU  - Chinnaiyan, Arul M
AU  - Aldape, Kenneth
AU  - Pfister, Stefan
AU  - Filbin, Mariella G
AU  - Bhaduri, Aparna
AU  - Venneti, Sriram
TI  - Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways.
JO  - Acta Neuropathologica Communications
VL  - 11
IS  - 1
SN  - 2051-5960
CY  - London
PB  - Biomed Central
M1  - DKFZ-2023-00323
SP  - 25
PY  - 2023
AB  - Globally decreased histone 3, lysine 27 tri-methylation (H3K27me3) is a hallmark of H3K27-altered diffuse midline gliomas (DMGs) and group-A posterior fossa ependymomas (PFAs). H3K27-altered DMGs are largely characterized by lysine-to-methionine mutations in histone 3 at position 27 (H3K27M). Most PFAs overexpress EZH inhibitory protein (EZHIP), which possesses a region of similarity to the mutant H3K27M. Both H3K27M and EZHIP inhibit the function of the polycomb repressive complex 2 (PRC2) responsible for H3K27me3 deposition. These tumors often arise in neighboring regions of the brainstem and posterior fossa. In rare cases PFAs harbor H3K27M mutations, and DMGs overexpress EZHIP. These findings together raise the possibility that certain cell populations in the developing hindbrain/posterior fossa are especially sensitive to modulation of H3K27me3 states. We identified shared molecular features by comparing genomic, bulk transcriptomic, chromatin-based profiles, and single-cell RNA-sequencing (scRNA-seq) data from the two tumor classes. Our approach demonstrated that 1q gain, a key biomarker in PFAs, is prognostic in H3.1K27M, but not H3.3K27M gliomas. Conversely, Activin A Receptor Type 1 (ACVR1), which is associated with mutations in H3.1K27M gliomas, is overexpressed in a subset of PFAs with poor outcome. Despite diffuse H3K27me3 reduction, previous work shows that both tumors maintain genomic H3K27me3 deposition at select sites. We demonstrate heterogeneity in shared patterns of residual H3K27me3 for both tumors that largely segregated with inferred anatomic tumor origins and progenitor populations of tumor cells. In contrast, analysis of genes linked to H3K27 acetylation (H3K27ac)-marked enhancers showed higher expression in astrocytic-like tumor cells. Finally, common H3K27me3-marked genes mapped closely to expression patterns in the human developing hindbrain. Overall, our data demonstrate developmentally relevant molecular similarities between PFAs and H3K27M DMGs and support the overall hypothesis that deregulated mechanisms of hindbrain development are central to the biology of both tumors.
KW  - Humans
KW  - Histones: genetics
KW  - Histones: metabolism
KW  - Lysine: genetics
KW  - Ependymoma: pathology
KW  - Glioma: genetics
KW  - Glioma: pathology
KW  - Rhombencephalon: pathology
KW  - Fluorocarbons
KW  - Mutation: genetics
KW  - Brain Neoplasms: genetics
KW  - Brain Neoplasms: pathology
KW  - Brain development (Other)
KW  - Cancer (Other)
KW  - Chromatin biology (Other)
KW  - Neuro-oncology (Other)
KW  - Onco-histones (Other)
KW  - Pediatric tumors (Other)
KW  - Histones (NLM Chemicals)
KW  - Lysine (NLM Chemicals)
KW  - Fluorocarbons (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:36759899
C2  - pmc:PMC9912509
DO  - DOI:10.1186/s40478-023-01514-z
UR  - https://inrepo02.dkfz.de/record/267545
ER  -